Biochemical and Mechanistic Insights into the Roles of Rad51 Paralogs in Homologous Recombination Repair
Rad51 旁系同源物在同源重组修复中作用的生化和机制见解
基本信息
- 批准号:10450660
- 负责人:
- 金额:$ 4.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:BRCA1 geneBRCA2 geneBindingBiochemicalBiologicalBiological AssayCancer-Predisposing GeneCell LineCellsCodeCollaborationsComplexDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDNA biosynthesisDNA replication forkDataDiseaseEpithelial ovarian cancerEtiologyFanconi&aposs AnemiaFellowshipFilamentGenetic studyGerm-Line MutationHereditary Breast CarcinomaHereditary Breast and Ovarian Cancer SyndromeHereditary Malignant NeoplasmHumanIndividualInheritedInvestigationKineticsKnock-outKnowledgeLinkMalignant NeoplasmsMalignant neoplasm of ovaryMammalian CellMapsMeasuresMediatingMentorsMethodsMicroscopyMolecularMutateMutationMutation AnalysisNonhomologous DNA End JoiningNucleoproteinsPALB2 genePathway interactionsPatientsPlatinumPlayPredispositionProcessProtein FamilyProteinsProtocols documentationRAD51C geneRegulationResearchResearch PersonnelResearch TrainingResolutionRoleSamplingSchemeSerousSingle-Stranded DNASiteSomatic MutationSystemTechniquesTestingTimeLineTrainingWorkXRCC2 geneXRCC3 genebasebrca genecareerchemotherapyexperimental studygenome integrityhomologous recombinationin vivoinnovationinsightmalignant breast neoplasmmultidisciplinarynovelparalogous genepatient stratificationpreservationrecombinational repairreconstitutionrecruitrepairedresistance mechanismresponsespatial relationshipspatiotemporalsynergismtherapy resistanttreatment responsetumor
项目摘要
PROJECT SUMMARY/ABSTRACT
Understanding the molecular pathways disrupted in breast and ovarian cancer is vital to combating these
devastating diseases. Hereditary susceptibility to cancer can be caused by germline mutations in the BReast
CAncer susceptibility genes BRCA1 and BRCA2. The BRCA genes code for proteins involved in homologous
recombination (HR) repair of DNA Double-Stranded Breaks (DSBs) and the protection of reversed replication
forks. BRCA2, in particular, is vital to HR as it loads RAD51 onto single-stranded DNA (ssDNA) forming a
nucleoprotein filament. The five RAD51 paralogs: RAD51B, RAD51C, RAD51D, XRCC2, and XRCC3 are a
family of proteins with homology to RAD51, have been implicated in HR regulation, and germline mutations have
been linked to familial breast and ovarian cancer. The RAD51 paralogs form two different complexes in human
cells but their functions and stoichiometric relationships in HR remain uncharacterized decades after their
discovery. The BCDX2 complex (RAD51B/C/D/XRCC2) and the CX3 complex (RAD51C and XRCC3) have yet
to be successfully purified for biochemical assays. Genetic studies have made little progress as knockout cell
lines for any one of the paralogs are not viable. This proposal will utilize novel methods to overcome these
obstacles and better characterize the roles of the RAD51 paralogs in HR. The first approach will determine
whether specific domains mediate an interaction between RAD51 paralog proteins and BRCA2 or PALB2
(Partner and Localizer of BRCA2). Second, the RAD51 paralogs will be purified from human cells using a unique
and innovative protocol we have developed. The individual paralogs, as well as the two paralog complexes, will
be tested to determine if synergy exists with BRCA2 in stimulating RAD51-mediated DNA strand exchange. In a
complementary cell biological approach, I will use a conditional system to systematically deplete individual
RAD51 paralogs, and their respective complexes, to observe if RAD51 foci formation is compromised in
response to DNA damage. Finally, in collaboration with Dr. Eli Rothenberg at NYU, we will utilize his expertise
in super-resolution microscopy to test the hypothesis that the RAD51 paralog complexes are recruited to DSBs
to perform specific functions during HR. Using this technique, I will create a timeline of recruitment and retention
at DSBs in the context of other HR proteins. This spatiotemporal information will inform us at which step in HR
the paralogs are active and their spatial relationships at a single DSB. Upon completion of the research and
training fellowship, the RAD51 paralogs will be significantly more understood, and the applicant will have
received extensive training. The multidisciplinary mentoring team will prepare the applicant for research
independence and a successful career as a cancer researcher.
项目摘要/摘要
了解乳腺癌和卵巢癌中破坏的分子途径对于对抗这些途径至关重要
毁灭性疾病。遗传性对癌症的敏感性可能是由乳房种系突变引起的
癌症敏感性基因BRCA1和BRCA2。 BRCA基因代码涉及同源的蛋白质
DNA双链断裂(DSB)的重组(HR)修复和反向复制的保护
叉子。尤其是BRCA2对HR至关重要,因为它将Rad51加载到形成A
核蛋白丝。五个RAD51旁系同源物:Rad51b,Rad51C,Rad51d,XRCC2和XRCC3是A
与Rad51同源的蛋白质家族已与人力资源调节有关,生殖线突变具有
与家族性乳腺癌和卵巢癌有关。 Rad51旁系同源物在人类中形成两个不同的复合物
细胞,但它们的功能和人力资源的化学计量关系在它们之后的几十年保持了几十年
发现。 BCDX2复合物(RAD51B/C/D/XRCC2)和CX3复合物(RAD51C和XRCC3)尚未
成功纯化用于生化测定。作为基因敲除细胞,遗传研究几乎没有取得进展
任何一个旁系同源物的线都不可行。该建议将利用新颖的方法来克服这些
障碍物和更好地表征了Rad51旁系同源物在人力资源中的作用。第一种方法将确定
特定域是否介导RAD51旁系同源蛋白与BRCA2或PALB2之间的相互作用是否介导
(BRCA2的合作伙伴和本地化)。其次,Rad51旁系同源物将使用独特的
和我们制定的创新协议。单个旁系同源物以及两个旁系同源络合物将
进行测试以确定BRCA2是否存在刺激RAD51介导的DNA链交换中的协同作用。在
互补的细胞生物学方法,我将使用条件系统系统地耗尽个人
Rad51旁系同源物及其各自的复合物,以观察Rad51焦点形成是否在
对DNA损伤的反应。最后,与纽约大学的Eli Rothenberg博士合作,我们将利用他的专业知识
在超分辨率显微镜中,测试了Rad51旁系同源络合物被募集到DSB的假设
在人力资源期间执行特定功能。使用此技术,我将创建一个招聘和保留时间表
在其他HR蛋白的背景下DSB。此时空信息将告知我们在人力资源部的哪个步骤
旁系同源物是活跃的,它们在单个DSB处的空间关系。研究完成后
培训奖学金,RAD51旁系同源物将被更加了解,申请人将拥有
接受了广泛的培训。多学科指导团队将为研究申请人做好准备
独立性和作为癌症研究员的成功职业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jacob Garrett Thrasher其他文献
Jacob Garrett Thrasher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jacob Garrett Thrasher', 18)}}的其他基金
Biochemical and Mechanistic Insights into the Roles of Rad51 Paralogs in Homologous Recombination Repair
Rad51 旁系同源物在同源重组修复中作用的生化和机制见解
- 批准号:
10650754 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
Biochemical and Mechanistic Insights into the Roles of Rad51 Paralogs in Homologous Recombination Repair
Rad51 旁系同源物在同源重组修复中作用的生化和机制见解
- 批准号:
10315679 - 财政年份:2021
- 资助金额:
$ 4.68万 - 项目类别:
相似国自然基金
DNA同源重组基因EXO1和BRCA2在早发性卵巢功能不全发病中的作用和致病机制研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
BRCA2基因新突变导致的甲基缺失引起高危家族卵巢/乳腺癌发生的机制研究
- 批准号:81972444
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
中国家族性乳腺癌BRCA1/2基因大片段重排断裂位点鉴定及功能研究
- 批准号:81772824
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
BRCA2基因肿瘤抑制新机制:抑制中心体过度复制
- 批准号:30771110
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
BACP1-BRCA2相互作用及其有丝分裂调控的研究
- 批准号:30470370
- 批准年份:2004
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Natural products inhibitors targeting homology-directed DNA repair for cancer therapy
针对癌症治疗的同源定向 DNA 修复的天然产物抑制剂
- 批准号:
10651048 - 财政年份:2023
- 资助金额:
$ 4.68万 - 项目类别:
Mapping the BRCA2 replication gap suppression domain to uncover themolecular mechanism of chemotherapy response
绘制 BRCA2 复制间隙抑制域图谱以揭示化疗反应的分子机制
- 批准号:
10679641 - 财政年份:2023
- 资助金额:
$ 4.68万 - 项目类别:
Defining the Roles of BRCA2 and RAD51 in PARPi Response
定义 BRCA2 和 RAD51 在 PARPi 反应中的作用
- 批准号:
10640159 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别:
Novel Mechanisms of MED12-TGFbeta-mediated resistance to PARP Inhibitors in BRCA-deficient Cancer Cells
MED12-TGFbeta 介导的 BRCA 缺陷癌细胞对 PARP 抑制剂耐药的新机制
- 批准号:
10665588 - 财政年份:2022
- 资助金额:
$ 4.68万 - 项目类别: